⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IKT News
Inhibikase Therapeutics, Inc. Common Stock
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
IKT
Form 8-K
sec.gov
IKT
Form 8-K
sec.gov
IKT
Form 8-K
sec.gov
IKT
Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity
globenewswire.com
IKT
Form 8-K
sec.gov
IKT
Form 8-K
sec.gov
IKT
Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH
globenewswire.com
IKT
Form 8-K
sec.gov
IKT
Inhibikase Therapeutics Announces Sale of $50 Million of Shares Through its At-the-Market (ATM) Facility
globenewswire.com
IKT